Virxsys Corporation
10Patents
4Active
10Granted
35Portfolio score
Filing activity: Aug 31, 2000 → Jun 22, 2011 · 3 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6627442B1 | Methods for stable transduction of cells with hiv-derived viral vectors | Chemistry; Metallurgy | 32 | Expired |
| US7399753B2 | Trans-splicing mediated photodynamic therapy | Chemistry; Metallurgy | 4 | Expired |
| US8053232B2 | Correction of alpha-1-antitrypsin genetic defects using spliceosome mediated RNA trans splicing | Chemistry; Metallurgy | 3 | Active |
| US7968334B2 | Expression of apoAI and variants thereof using spliceosome mediated RNA trans-splicing | Chemistry; Metallurgy | 2 | Expired |
| US6835568B2 | Regulated nucleic acid expression system | Chemistry; Metallurgy | 1 | Expired |
| US7427474B2 | High-throughput methods for identifying gene function using lentiviral vectors | Chemistry; Metallurgy | 0 | Expired |
| US7871795B2 | Targeted trans-splicing of highly abundant transcripts for in vivo production of recombinant proteins | Chemistry; Metallurgy | 0 | Active |
| US7879321B2 | Use of RNA trans-splicing for antibody gene transfer and antibody polypeptide production | Chemistry; Metallurgy | 0 | Expired |
| US8043611B2 | Regulated nucleic acid expression system | Chemistry; Metallurgy | 0 | Active |
| US8883753B2 | Expression of apoAI and variants thereof using spliceosome mediated RNA trans-splicing | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.